Primary Care Support
Federations, Practice Mergers, Income Generation & Access
I will work one to one - unearth where the levers and incentives are within the systems, e.g. gain share agreements, incentive schemes, subcontracts from secondary care, direct contracts from the CCGs, all provide potential routes along with a number of other items we use in our work. When aligned with the right stakeholders you have the perfect conditions develop and implement great programmes.
I will teach your teams how to dramatically improve market access and sales. This is a practical solution oriented approach based upon my work and access to the NHS. This project based upon my experience, everything is tried and tested and I already have remarkable outcomes, with one high quality and standardised approach, without unwarranted variation, working within hub and spoke models across the NHS.
This is a programme I ran twice in 2017 with great outcomes for the two pharmaceutical companies that engaged me. My work provides insight, challenge and suggestion using the process I use when meeting a group for the first time, along with how he works to identify and then get access to the right people. My expertise and experience will support you to deliver your vision and outcomes. It provides a sustainable and resilient approach ensuring you are able to meet not just current challenges, but future challenges as well.
For more information on how we can help you, whether you are at the early stages of considering forming a federation
or you are already up and running please contact
Frances on 0845 388 0302 or
Coaching and mentoring for Pharmaceutical Companies
For the Pharmaceutical Industry to be viewed as a partner, you need to understand the current NHS agenda, the evolution of New Models of Care and the intended impact of Sustainability and Transformation Partnerships (STPs).
Whether it's hubs of 30,000 to 50,000 (e.g. Primary Care Home - PCH), Multispecialty Community Providers (MCP), Primary and Acute Care Systems (PACS), Accountable Care Organisations (ACO), Integrated Care Systems (ICS) or Accountable Care Partnerships (ACP), I can explain the differences and demonstrate how you can engage with the right client base using only six questions.
Your account planning will undoubtedly be affected by what's happening within your client base, where the NHS landscape continues to change. Do you understand what's happening with CCGs, STPs, New Models of Care and the impact this will have on you?
Time and finances are at a premium, regulation is stricter than it has ever been and access is getting harder to achieve in the traditional model. Pharmaceutical companies who have historically worked in partnership with the NHS are more frequently experiencing greater difficulty in accessing their main marketplace. Often the access that is achieved does not bring the results required.
There is a solution; a new client base you can target that will engage, work with you and seek out joint initiatives that deliver improved patient outcomes within financially viable solutions.
Within Scott McKenzie UK we already have many successful live examples; models that effectively support the Practices to transform clinical vision into reality, for example creating more cost-effective treatment pathways, delivering significant efficiency for the practices, supporting seven day opening and working with other key health economy stakeholders.
Many of these projects are worked via the newly formed GP Federations, Super Practices, Hubs of 30,000 to 50,000 patients and many are working in partnership with the pharmaceutical industry.
Our process ensures a unique approach for each Pharmaceutical Company, one that best reflects your own circumstances, ways of working and relationships; there is no one size that will fit every need, hence we support you to turn your vision into reality this is where our proven methods are ideal.
With experience of working in NHS provider and commissioner roles, and within the pharmaceutical industry, I have developed a programme that offers a solution to resolving access and sales issues. Having recognised how important pharmaceutical companies are to the future of the NHS, both as a support or a valued partner, my new programme offers a blend of classroom learning and one to one field coaching. Delegates will learn;